China's Sinovac Biotech gets govt approval for more bird flu vaccine trials |
|
|
|
Published
:
Thu, 10 May 2007 11:04
|
BEIJING (XFN-ASIA) - Sinovac Biotech Ltd said China's State Food and Drug Administration has granted it approval to begin the Phase II clinical trial of Panflu, a human use vaccine against the H5N1 bird flu virus.The vaccine was jointly developed with China's Center for Disease Control, the company said in a statement, adding that two versions of the vaccine have been approved for clinical trials.'We are developing Panflu to vaccinate humans against H5N1 given the significant concern that it may evolve into a virus capable of human-to-human transmission,' said company president and CEO Yin Weidong.sean.mangieri@xfn.com
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2374.41 |
-16.87 (
-0.71 %)
|
| SYMBOL (
2010-03-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
12:35pm )
|
|
2650.00 |
+52.00 (
2.00 %)
|
|
WHITBREAD
(
12:35pm )
|
|
1540.00 |
+21.00 (
1.37 %)
|
| SYMBOL (
2010-03-19 )
|
| LAST |
CHANGE
|
| SYMBOL (
2010-03-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
FDA approves first bird flu vaccine 